Quest Diagnostics price target raised to $165 from $150 at Piper Sandler
The Fly

Quest Diagnostics price target raised to $165 from $150 at Piper Sandler

Piper Sandler raised the firm’s price target on Quest Diagnostics (DGX) to $165 from $150 following quarterly results. The firm remains on the sidelines with a Neutral rating on the shares.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App